Related references
Note: Only part of the references are listed.Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA
Patricia Vella Bonanno et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2019)
Precision medicine and monoclonal antibodies: breach of promise?
Livio Garattini et al.
CROATIAN MEDICAL JOURNAL (2019)
Comment on: 'The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study'
Livio Garattini et al.
PHARMACOECONOMICS (2019)
Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs
Rick A. Vreman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Towards a regulation of HTA in Europe: the proposal from the European Commission
Antonio Migliore
EXPERT REVIEW OF MEDICAL DEVICES (2019)
PERSPECTIVE: SOME CONCLUSIONS FROM MY LIFE IN HEALTH TECHNOLOGY ASSESSMENT
H. David Banta
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2018)
THE ADDED VALUE OF INTEGRATE-HTA GUIDANCE IN THE WORK PROCESSES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES
Gert Jan van der Wilt et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2017)
Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?
Livio Garattini et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2017)
Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated With NewCancer Medicines
Sebastian Salas-Vega et al.
JAMA ONCOLOGY (2017)
Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries
S. Kleijnen et al.
ANNALS OF ONCOLOGY (2016)
Ethical analysis in HTA of complex health interventions
Kristin Bakke Lysdahl et al.
BMC MEDICAL ETHICS (2016)
Health Technology Assessment in the Context of Adaptive Pathways for Medicines in Europe: Challenges and Opportunities
J. C. Bouvy et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Real-world evidence in economic evaluations: Really realistic?
L. Garattini et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2016)
European Medicines Agency: leave the UK but remain the same
Livio Garattini et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2016)
Assessing the relative efficacy of new drugs: an emerging opportunity
Hans-Georg Eichler et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
HTA AND ITS LEGAL ISSUES: A FRAMEWORK FOR IDENTIFYING LEGAL ISSUES IN HEALTH TECHNOLOGY ASSESSMENT
Daniel Widrig et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2014)
A history of health technology assessment at the European level
David Banta et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2009)
Practical tools and methods for health technology assessment in Europe: Structures, methodologies, and tools developed by the European network for Health Technology Assessment, EUnetHTA
Finn Borlum Kristensen et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2009)
International comparison of the definition and the practical application of health technology assessment
E Draborg et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2005)
The development of health technology assessment
D Banta
HEALTH POLICY (2003)
Share Paper
